SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-17-000304
Filing Date
2017-03-24
Accepted
2017-03-23 20:02:51
Documents
8
Period of Report
2017-03-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT htbx_8k.htm 8-K 20794
2 UNDERWRITING AGREEMENT htbx_ex1z1.htm EX-1.1 233694
3 OPINION htbx_ex5z1.htm EX-5.1 8254
4 PRESS RELEASE htbx_ex99z1.htm EX-99.1 7829
5 PRESS RELEASE htbx_ex99z2.htm EX-99.2 8089
6 GRAPHIC htbx_ex5z1001.jpg GRAPHIC 9022
7 GRAPHIC htbx_ex99z1001.jpg GRAPHIC 24912
8 GRAPHIC htbx_ex99z2001.jpg GRAPHIC 24912
  Complete submission text file 0001553350-17-000304.txt   361248
Mailing Address 801 CAPITOLA DRIVE DURHAM NC 27713
Business Address 801 CAPITOLA DRIVE DURHAM NC 27713 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 17710955
SIC: 2834 Pharmaceutical Preparations